Trial of Inhaled Nitric Oxide (iNO) on Ischemia / Reperfusion Injury During Orthotopic Liver Transplantation With Marginal Grafts



Status:Archived
Conditions:Peripheral Vascular Disease, Cardiology
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:July 2010
End Date:July 2012

Use our guide to learn which trials are right for you!

Randomized, Blinded, Controlled Trial of Inhaled Nitric Oxide (iNO) on Ischemia / Reperfusion Injury During Orthotopic Liver Transplantation With Marginal Grafts.


This study is being done to determine if patients receiving (iNO) will have increased liver
function and less damage from IR than patients who do not receive (iNO).



We found this trial at
1
site
?
mi
from
Dallas, TX
Click here to add this to my saved trials